FDA Inspection
Dabur India LimitedDabur India Limited – FDA Inspection, Dec 6, 2019
Record Details
This FDA Inspection record concerns Dabur India Limited, with an inspection on December 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Dabur India Limited
- Inspection Date
- December 6, 2019
- Product Type
- Drugs
View Company Profile
ID · 916d29e7-b5d6-4a14-bd1f-a8f6873607cf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1112104
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dabur India Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2026 | OAI | Office of Inspections and Investigations | Drug Quality Assurance |
| October 14, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dabur India Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.